Hélène Hardy

Author PubWeight™ 4.02^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Changes in bone mineral density after 96 weeks of treatment with atazanavir/ritonavir or lopinavir/ritonavir plus tenofovir DF/emtricitabine in treatment-naive patients with HIV-1 infection: the CASTLE body composition substudy.	J Acquir Immune Defic Syndr	2015	0.84
2	Atazanavir pharmacokinetics, efficacy and safety in pregnancy: a systematic review.	Antivir Ther	2012	0.83
3	Clinical and pharmacogenetic factors affecting neonatal bilirubinemia following atazanavir treatment of mothers during pregnancy.	AIDS Res Hum Retroviruses	2013	0.81
4	Comparison of body composition changes between atazanavir/ritonavir and lopinavir/ritonavir each in combination with tenofovir/emtricitabine in antiretroviral-naïve patients with HIV-1 infection.	Clin Drug Investig	2014	0.78
5	Development and field testing of an HIV medication touch screen computer patient adherence tool with telephone-based, targeted adherence counseling.	J Int Assoc Provid AIDS Care	2012	0.76